Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high u...
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics a...
llumina a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series custo...
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PR...
Kiromic BioPharma, reports favorable eight-month follow-up results from the first patient enrolled in its Deltacel-01 Phase 1 clinical trial. This trial ...
Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing &pou...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the publication of a peer-reviewed stud...
Advanced Clinical, a privately held clinical research services organization committed to providing a better clinical experience across the drug developme...
The collaboration aims to identify and develop accessible and mini-invasive blood biomarkers specific to tau pathology in the brain These tools ...
Nexcella, Inc. a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced tha...
Triastek Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals, announced that it has entered into a research collaboration and platfor...
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to acceler...
Pfizer Inc. announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gen...
© 2025 Biopharma Boardroom. All Rights Reserved.
